German ban on Ranbaxy’s Dewas product expands to entire EU

NEW DELHI: Adding to Ranbaxy’s regulatory troubles overseas, certain drugs produced at its Dewas plant have been barred from export to all member countries of the European Union for non-compliance to ‘good manufacturing practice’ norms.

The EU sanction follows a decision taken by German authorities in this regard for Ranbaxy’s Dewas plant, which has also faced inspections by authorities from Australia and Canada. Besides, the US drug watchdog FDA has already banned products made at R ..